Stock Fundamentals

Company Information

▼
Company Name
Cardiol Therapeutics Inc Class A
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: CA14161Y2006
CIK: 0001702123
Currency: USD
Full Time Employees: 18
Phone: 289 910 0850
Website: https://www.cardiolrx.com
Fiscal Year End: December
IPO Date: Jan 15, 2019
Description:

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

Address:

2265 Upper Middle Road East, Oakville, ON, Canada, L6H 0G5

Directors & Officers

▼
Name Title Year Born
Mr. David G. Elsley MBA President, CEO & Director NA
Mr. Christopher J. Waddick C.A., C.M.A., CPA, MBA CFO, Corporate Secretary & Director NA
Mr. Bernard Lim B.Sc. Chief Operating Officer NA
Dr. Andrew Warwick Hamer M.D. Chief Medical Officer and Head of Research & Development 1962
Trevor Burns Investor Relations NA
Mr. John A. Geddes BSCPT, MBA Vice President of Corporate Development NA

Institutional Holders

▼
Holder Name Shares Date Reported % Out Value % Change
Tejara Capital Ltd 2.63M Sep 30, 2025 2.36% $1.47 -19.47%
AdvisorShares Investments, LLC 557.39K Sep 30, 2025 0.50% $0.10 -34.99%
Bank of America Corp 551.05K Sep 30, 2025 0.49% $0.00 1,982.98%
Marshall Wace Asset Management Ltd 544.32K Sep 30, 2025 0.49% $0.00 0.00%
Citadel Advisors Llc 463.46K Sep 30, 2025 0.42% $0.00 0.00%
INTEGRITY ALLIANCE, LLC. 435.03K Dec 31, 2025 0.39% $0.02 0.00%
Two Sigma Investments LLC 406.94K Dec 31, 2025 0.36% $0.00 75.14%
The Goldman Sachs Group Inc 321.80K Sep 30, 2025 0.29% $0.00 459.65%
Mmcap International Inc. Spc 208.95K Dec 31, 2025 0.19% $0.02 -28.70%
Morgan Stanley - Brokerage Accounts 156.33K Sep 30, 2025 0.14% $0.00 56.52%
Virtu Financial LLC 144.06K Sep 30, 2025 0.13% $0.01 0.00%
Sheets Smith Investment Management 142.10K Sep 30, 2025 0.13% $0.10 0.00%
Summit Financial, LLC 129.01K Sep 30, 2025 0.12% $0.00 0.00%
Jane Street Group LLC 116.35K Sep 30, 2025 0.10% $0.00 0.00%
Knoll Capital Management LP 100.00K Dec 31, 2025 0.09% $0.04 0.00%
We Are One Seven, LLC 100.00K Sep 30, 2025 0.09% $0.00 0.00%
1832 Asset Management L.P 100.00K Dec 31, 2025 0.09% $0.00 0.00%
Susquehanna International Group, LLP 93.40K Sep 30, 2025 0.08% $0.00 366.45%
UBS Group AG 53.49K Sep 30, 2025 0.05% $0.00 -61.59%
Geode Capital Management, LLC 52.44K Sep 30, 2025 0.05% $0.00 0.00%

Shares Statistics

▼
Shares Outstanding: 111.68M
Shares Float: 75.33M
% Insiders: 313.80%
% Institutions: 2,004.20%
Short % Float: 1.92%

🏆 Top 10 Institutional Holders

▼
Rank Holder Name Shares Held % of Shares Change Date Reported
1 Tejara Capital Ltd 2.63M 2.36% ▼ 19.47% Sep 30, 2025
2 AdvisorShares Investments, LLC 557.39K 0.50% ▼ 34.99% Sep 30, 2025
3 Bank of America Corp 551.05K 0.49% ▲ 1,982.98% Sep 30, 2025
4 Marshall Wace Asset Management Ltd 544.32K 0.49% ▲ 0.00% Sep 30, 2025
5 Citadel Advisors Llc 463.46K 0.42% ▲ 0.00% Sep 30, 2025
6 INTEGRITY ALLIANCE, LLC. 435.03K 0.39% ▲ 0.00% Dec 31, 2025
7 Two Sigma Investments LLC 406.94K 0.36% ▲ 75.14% Dec 31, 2025
8 The Goldman Sachs Group Inc 321.80K 0.29% ▲ 459.65% Sep 30, 2025
9 Mmcap International Inc. Spc 208.95K 0.19% ▼ 28.70% Dec 31, 2025
10 Morgan Stanley - Brokerage Accounts 156.33K 0.14% ▲ 56.52% Sep 30, 2025

Valuation Metrics

▼
Enterprise Value: $104.28M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $113.91M
EBITDA: $-36.41M
Book Value: $0.08
Earnings/Share: $-0.30
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -148.83%
ROE (TTM): -347.98%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

▼

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

▼

Financial Ratios (Yearly)

▼

Financial Ratios (Quarterly)

▼

Earnings History

▼

Balance Sheet (Yearly)

▼

Financial Ratios

▼
Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 4.52x 0.00x 0.22x N/A 0.00x
2023-12-31 4.36x 0.00x 0.23x N/A 0.00x
2022-12-31 6.27x 0.00x 0.16x N/A 0.00x
2021-12-31 7.53x 0.00x 0.13x N/A 0.00x
2020-12-31 5.94x 0.00x 0.17x N/A 0.00x
2019-12-31 20.81x 0.00x 0.05x -17,543.88x 0.00x
2018-12-31 11.22x 0.01x 0.10x -11.14x -0.04x
2017-12-31 14.06x 0.07x 0.11x -26.24x -0.13x

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CRDL.US!